Price $271.91 |
Market Cap
142.67B
|
Sector Health Care |
Div. Growth
9.90%
|
|
P/E
19.2
|
P/B
18.86
|
P/S
5.38
|
Dividend %
3.20%
|
|
P/CF
5.8
|
P/FCF
29.5
|
Op. Cash Flow
10.58M
|
FCF
9.1
|
|
Op. Margin
33.70%
|
Net Margin
28.20%
|
ROE
129.10%
|
ROI
20.80%
|
|
ROA
9.00%
|
EPS Growth
13.00%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc (COLL) | $34.74 | - | - | 752M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $24.23 | - | - | 1.19B | Strong Buy |
| Marizyme Inc (MRZM) | $0.10 | - | - | 8.6M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.81 | - | - | 14.8M | Strong Buy |
| Omnicell Inc (OMCL) | $28.18 | - | - | 1.32B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
